Browse Category

Earnings Reports News 5 December 2025

Spanish Broadcasting System Q3 2025 Earnings: Profit Doubles as Puerto Rico TV Sale and Cost Cuts Offset 13% Revenue Drop

Spanish Broadcasting System Q3 2025 Earnings: Profit Doubles as Puerto Rico TV Sale and Cost Cuts Offset 13% Revenue Drop

Spanish Broadcasting System (SBS) has turned a tough advertising market into a profitable quarter, using expense cuts, a TV asset sale in Puerto Rico and rapid digital growth to more than double its third‑quarter net income year over year—even as revenue fell double digits. Spanish Broadcasting System+1 Industry trades and the company’s own earnings package, released December 3 and followed by coverage this week from Radio Ink, Radio & Television Business Report (RBR+TVBR) and Radio Online, frame the quarter as a story of aggressive cost discipline and a pivot toward streaming and live events rather than a simple revenue decline.
5 December 2025
ServiceTitan (NASDAQ: TTAN) Surges After Q3 Earnings Beat and Wave of Analyst Calls on December 5, 2025

ServiceTitan (NASDAQ: TTAN) Surges After Q3 Earnings Beat and Wave of Analyst Calls on December 5, 2025

ServiceTitan, Inc. (NASDAQ: TTAN) jumped sharply on Friday, December 5, 2025, as investors reacted to its first fiscal third‑quarter report since going public and a flurry of fresh analyst price‑target changes. The home‑services software specialist beat Wall Street expectations on both revenue and earnings, boosted cash flow, and reinforced its long‑term growth story built around AI‑driven tools for contractors. Stock Titan+1 Roughly one year after its December 2024 IPO at $71 per share—which saw the stock surge about 42% on its first trading day and value the company near $9 billion—ServiceTitan stock is again back in the spotlight. Reuters+1 ServiceTitan
5 December 2025
Cooper Companies (COO) Stock Jumps on Q4 2025 Earnings Beat, Strategic Review and Fresh Analyst Upgrades

Cooper Companies (COO) Stock Jumps on Q4 2025 Earnings Beat, Strategic Review and Fresh Analyst Upgrades

Published: December 5, 2025 Cooper Companies, Inc. (NASDAQ: COO), the medical device group behind CooperVision contact lenses and CooperSurgical women’s health products, is back in the spotlight after a busy 24 hours of earnings, strategic moves and analyst reactions. Following a fiscal Q4 2025 earnings beat, a new long‑term free cash flow target, and the launch of a formal strategic review alongside a board shake‑up, COO shares have swung sharply higher. The stock opened near $90 on Friday and is now trading in the low $80s after being up as much as the mid‑teens in percentage terms earlier in the
Dollar General (DG) Stock Soars After Q3 2025 Beat and Raised Guidance – Is There More Upside Ahead?

Dollar General (DG) Stock Soars After Q3 2025 Beat and Raised Guidance – Is There More Upside Ahead?

On December 5, 2025, Dollar General Corporation (NYSE: DG) is firmly back in Wall Street’s spotlight. After a strong third‑quarter 2025 earnings beat, a sizeable guidance raise, and a fresh round of analyst price‑target upgrades, Dollar General stock has rallied sharply and is now trading near new 52‑week highs. StockStory+2Chain Drug Review+2 Below is a detailed, news-style breakdown of the latest numbers, strategy updates, analyst forecasts, and key risks that investors are watching today. Dollar General stock today: trading near the top of its recent range As of the latest trade on December 5, 2025, Dollar General stock is around
Smith & Wesson (SWBI) Stock Soars After Q2 2026 Earnings: Dividend, Outlook and Forecasts as of December 5, 2025

Smith & Wesson (SWBI) Stock Soars After Q2 2026 Earnings: Dividend, Outlook and Forecasts as of December 5, 2025

Smith & Wesson Brands, Inc. (NASDAQ: SWBI) just delivered one of its biggest single‑day moves in recent years. As of Friday, December 5, 2025, the stock is trading around $10.64, up roughly 19% from Thursday’s close, after the gun maker reported fiscal Q2 2026 results that beat profit expectations, showcased strong cash generation and reaffirmed a hefty dividend. Nasdaq+1 Here’s a detailed look at what’s driving SWBI today, what management is signaling for the months ahead, and how Wall Street currently values the stock. Smith & Wesson stock today: a sharp reversal from mid‑2025 gloom As of late trading on
Visa Stock (V) in December 2025: Earnings Strength, AI Bets and 2026 Price Targets

Visa Stock (V) in December 2025: Earnings Strength, AI Bets and 2026 Price Targets

Published: December 5, 2025 — informational only, not investment advice. Visa stock today: price, valuation and sentiment As of the close on December 5, 2025, Visa Inc. (NYSE: V) trades around $331.78 per share, giving the payments giant a market capitalization close to $600 billion. MarketBeat Recent MarketBeat filings put Visa’s 12‑month trading range at roughly $299 to $375, with a trailing P/E ratio near 32, a PEG ratio around 2, and beta below 1.0 (≈0.82) — classic “quality compounder” characteristics rather than deep‑value pricing. MarketBeat+1 Visa’s board raised the quarterly dividend by 14% to $0.67 per share after the
Marvell Technology (MRVL) Stock on December 5, 2025: AI Earnings, Celestial AI Deal and Ontario Expansion Ignite 2026 Outlook

Marvell Technology (MRVL) Stock on December 5, 2025: AI Earnings, Celestial AI Deal and Ontario Expansion Ignite 2026 Outlook

Marvell Technology, Inc. (NASDAQ: MRVL) is back in the AI spotlight. As of the close on December 5, 2025, the stock trades around $98.89, up about 0.7% on the day, after a sharp two‑week rally powered by record AI‑driven earnings, a multi‑billion‑dollar photonics acquisition and fresh expansion plans in Canada.MarketBeat Yet despite the rebound, Marvell shares remain well below their 52‑week high and are still down double digits year‑to‑date, even as Wall Street upgrades pile in and long‑term AI infrastructure forecasts become more aggressive.MarketBeat+2Finviz+2 All figures and news in this article are current as of December 5, 2025. 1. Marvell
JPMorgan Chase (JPM) Stock on December 5, 2025: New $354 Price Target, Earnings Beat and 2026 Outlook Explained

JPMorgan Chase (JPM) Stock on December 5, 2025: New $354 Price Target, Earnings Beat and 2026 Outlook Explained

Date: December 5, 2025 – All figures as of mid‑day U.S. trading unless otherwise noted. This article is for informational purposes only and is not investment advice. JPMorgan Chase stock price today: near record highs JPMorgan Chase & Co. (NYSE: JPM) is trading around $317 per share in Friday’s session, up slightly on the day and hovering close to all‑time highs. Real‑time feeds show an intraday range roughly between $315 and $318, with the latest trade near $317.30 as of about 15:21 UTC. ChartExchange Key near‑term stats: On recent metrics from MarketBeat, JPMorgan trades on a P/E of ~15.6–15.7, with
5 December 2025
Oracle (ORCL) Stock Today: AI Cloud Backlog, Debt Warnings and What to Expect from Dec. 10 Earnings

Oracle (ORCL) Stock Today: AI Cloud Backlog, Debt Warnings and What to Expect from Dec. 10 Earnings

Oracle Corporation (NYSE: ORCL) is back in the spotlight on December 5, 2025, as its stock rebounds in pre‑market trading while Wall Street debates whether the company is a generational AI infrastructure winner or a highly leveraged credit risk. As of late morning on December 5, Oracle shares trade around $217 per share, modestly higher on the day and up roughly 3% from Wednesday’s close, giving the company a market value of about $610 billion.MarketBeat That move follows a 3.18% pre‑market jump earlier in the session, driven by renewed optimism around Oracle’s AI‑driven cloud strategy.AInvest The stakes are high: Oracle
Snowflake (SNOW) Stock Falls After Q3 Beat: AI Deals, Analyst Targets and Outlook as of December 5, 2025

Snowflake (SNOW) Stock Falls After Q3 Beat: AI Deals, Analyst Targets and Outlook as of December 5, 2025

Snowflake Inc. (NYSE: SNOW) is back in the spotlight after a sharp post‑earnings selloff, even as the cloud data platform continues to post strong growth and headline‑grabbing AI partnerships. On December 5, 2025, investors are weighing a classic growth‑stock dilemma: solid fundamentals and powerful AI tailwinds on one side, and rich valuations plus slowing growth and margin pressure on the other. Key Takeaways Snowflake Stock Today: Price, Valuation and 52‑Week Context As of mid‑day trading on December 5, 2025, Snowflake shares change hands at roughly $229–$230, down modestly on the day after Thursday’s steep drop.StockAnalysis Key snapshot metrics: Even after
Bank of Montreal Q4 2025 Earnings: Dividend Hike, Profit Surge and What It Means for BMO Stock in 2026

Bank of Montreal Q4 2025 Earnings: Dividend Hike, Profit Surge and What It Means for BMO Stock in 2026

BMO Financial Group has closed out 2025 with a powerful combination that dividend and bank‑stock investors love to see: strong profit growth, a higher payout, and a solid capital cushion. On Thursday, Bank of Montreal (TSX: BMO, NYSE: BMO) reported a fourth‑quarter profit of C$2.30 billion, essentially flat year‑on‑year, while adjusted earnings jumped as credit costs fell and capital markets roared back. Full‑year profit climbed double‑digits, and the board approved another increase to the bank’s common share dividend. BMO+1 Below is a breakdown of the numbers, the strategy behind them, and how analysts see BMO stock heading into 2026. Q4 2025
Samsara (IOT) Stock Today: Q3 FY2026 Earnings Beat, First GAAP Profit and a Wave of New $50 Price Targets

Samsara (IOT) Stock Today: Q3 FY2026 Earnings Beat, First GAAP Profit and a Wave of New $50 Price Targets

As of December 5, 2025, Samsara Inc. (NYSE: IOT) has just delivered a landmark quarter: its first ever GAAP profit, another round of 29% top-line growth, and a fresh batch of Wall Street price targets clustered around $50 per share. Yet the stock is still trading in the low $40s and remains well below its 2025 peak, leaving investors debating whether IOT is a high‑growth bargain or a richly priced momentum story. Below is a detailed breakdown of the latest news, forecasts, and analyses around Samsara stock as of December 5, 2025. Samsara stock today: price, range and recent performance
Ping An Insurance (2318 HK, 601318) Stock Jumps Toward 52‑Week High on Morgan Stanley Upgrade and Strong 2025 Earnings Momentum

Ping An Insurance (2318 HK, 601318) Stock Jumps Toward 52‑Week High on Morgan Stanley Upgrade and Strong 2025 Earnings Momentum

As of Friday, 5 December 2025, shares of Ping An Insurance (Group) Company of China, Ltd. (HKEX: 2318, 82318; SSE: 601318; OTC: PNGAY) are rallying hard, supported by a fresh Morgan Stanley upgrade, accelerating earnings in 2025, a growing healthcare footprint, and a string of top‑tier ESG ratings. Ping An share price today: sharp move higher on heavy volume Ping An’s Hong Kong–listed H‑shares (2318 HK) closed on 5 December at HK$60.45, up 6.71% on the day, after trading between HK$56.75 and HK$60.45. Turnover was unusually strong, with about 99 million shares changing hands, compared with roughly 14 million the
Hewlett Packard Enterprise (HPE) Stock: Q4 2025 Earnings, AI Server Slowdown and Analyst Forecasts as of December 5, 2025

Hewlett Packard Enterprise (HPE) Stock: Q4 2025 Earnings, AI Server Slowdown and Analyst Forecasts as of December 5, 2025

HPE Stock in Focus After Q4 2025 Earnings and AI Guidance Hewlett Packard Enterprise Company (NYSE: HPE) is back in the spotlight after releasing its fiscal Q4 2025 results on December 4 and updating guidance for 2026. The company reported record quarterly revenue and gross profit, but a cautious outlook for AI server sales triggered sharp swings in the share price and a fresh wave of analyst revisions. Hewlett Packard Enterprise+1 On December 4, HPE shares closed at $22.90, up about 2.9% for the day. In after-hours and premarket trading on December 5, the stock fell close to $21—down roughly
5 December 2025
ChargePoint (CHPT) Stock After Q3 2026 Earnings: Debt Deal, Target Cut and What’s Next for the EV Charging Leader

ChargePoint (CHPT) Stock After Q3 2026 Earnings: Debt Deal, Target Cut and What’s Next for the EV Charging Leader

Updated December 5, 2025 – For informational purposes only, not investment advice. ChargePoint’s High‑Voltage Week ChargePoint Holdings Inc. (NYSE: CHPT) has just packed a lot of news into a few weeks: At the same time, the stock is trading around $8.5 per share (Dec 4 close), up from the sub‑$1 levels that forced a 1‑for‑20 reverse split in July, but still down roughly 60% year‑to‑date and almost 99% from its post‑SPAC highs on a split‑adjusted basis. StockAnalysis+2Investing.com+2 Here’s how the latest earnings, balance‑sheet moves, analyst views and industry trends fit together as of December 5, 2025. Q3 FY 2026: A
SentinelOne (NYSE: S) Stock After Q3 Earnings: Double‑Digit Growth, CFO Exit and AWS AI Push Shape 2026 Outlook

SentinelOne (NYSE: S) Stock After Q3 Earnings: Double‑Digit Growth, CFO Exit and AWS AI Push Shape 2026 Outlook

SentinelOne, Inc. (NYSE: S) has just delivered a busy week: strong third‑quarter results, softer‑than‑expected guidance, a surprise CFO departure and a fresh wave of AI‑focused integrations with Amazon Web Services. As of December 5, 2025, the cybersecurity stock sits in the crosshairs of two powerful forces: improving profitability and mounting investor caution. On December 4, shares closed at $16.97, up a fraction on the day, but the Q3 report and outlook knocked the stock more than 8% lower in after‑hours and pre‑market trading, to roughly the mid‑$15 range.ChartMill+1 According to data tracked by Reuters and Zacks, SentinelOne shares are down
Ulta Beauty (ULTA) Stock Jumps After Q3 Beat and Raised 2025 Outlook: What Investors Need to Know Today

Ulta Beauty (ULTA) Stock Jumps After Q3 Beat and Raised 2025 Outlook: What Investors Need to Know Today

As of the morning of December 5, 2025, Ulta Beauty, Inc. (NASDAQ: ULTA) is firmly in the spotlight. After delivering a stronger‑than‑expected third quarter and raising its full‑year 2025 guidance, ULTA stock is trading more than 6% higher in pre‑market action, rising from Thursday’s close of $533.97 to around $566.79. StockAnalysis The move caps a powerful year‑to‑date rally and raises a key question for investors and traders: is Ulta Beauty stock still a buy after the post‑earnings spike, or is optimism finally priced in? Below is a rundown of the latest news, forecasts, and analyses as of December 5, 2025,
DocuSign (DOCU) Stock After Q3 2026 Earnings: AI Pivot Deepens as Shares Slide – December 5, 2025

DocuSign (DOCU) Stock After Q3 2026 Earnings: AI Pivot Deepens as Shares Slide – December 5, 2025

Updated: December 5, 2025 – suitable for Google News & Discover DocuSign, Inc. (NASDAQ: DOCU) is back in the spotlight after reporting fiscal Q3 2026 results on December 4 that beat Wall Street expectations on both revenue and earnings, while reiterating its strategic shift from pure e‑signature to an AI‑driven Intelligent Agreement Management (IAM) platform. Yet the stock is trading well below its 2025 highs as investors weigh modest single‑digit growth against strong profitability and an ambitious AI roadmap. DocuSign Investors+224/7 Wall St.+2 As of early trading on December 5, 2025, DocuSign shares change hands around $71 per share, leaving
Salesforce Stock Pops as Q3 2026 Earnings, AI Deals and AstraZeneca Partnership Lift Guidance — But Investor AI Skepticism Lingers

Salesforce Stock Pops as Q3 2026 Earnings, AI Deals and AstraZeneca Partnership Lift Guidance — But Investor AI Skepticism Lingers

Salesforce (NYSE: CRM) has triggered a fresh wave of headlines after posting record third‑quarter fiscal 2026 results, raising its full‑year outlook and signing a high‑profile AI deal with AstraZeneca. Yet despite the post‑earnings stock pop and new enterprise wins, CEO Marc Benioff is still fighting to convince Wall Street that Salesforce’s aggressive artificial intelligence strategy will translate into lasting shareholder returns. Salesforce Investor Relations+2Reuters+2 Q3 2026 by the numbers: record revenue, fatter margins For its fiscal third quarter ended October 31, 2025, Salesforce reported: On the bottom line, Salesforce delivered adjusted EPS of $3.25, handily beating the roughly $2.86 Wall
Rubrik Stock (RBRK) Jumps on Surprise Q3 Profit – Is the AI Security Darling Still a Buy?

Rubrik Stock (RBRK) Jumps on Surprise Q3 Profit – Is the AI Security Darling Still a Buy?

Rubrik, Inc. (NYSE: RBRK) has just delivered the kind of quarter that rewrites a stock’s story in a single trading session. After reporting a surprise profit and rapid revenue growth for its fiscal third quarter 2026 (three months ended October 31, 2025), shares spiked in after‑hours trading and remain sharply higher as of December 5, 2025. The stock is trading around $70–72 per share today, with a closing price of $70.43 on December 4 and a post‑earnings after‑hours spike that briefly pushed the price above $82. StockAnalysis That leaves Rubrik up more than 120% from its April 2024 IPO price
1 156 157 158 159 160 202

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop